US Bancorp DE Sells 3,134 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

US Bancorp DE lowered its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) by 10.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 26,967 shares of the medical instruments supplier’s stock after selling 3,134 shares during the quarter. US Bancorp DE’s holdings in DENTSPLY SIRONA were worth $765,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of XRAY. MetLife Investment Management LLC raised its holdings in shares of DENTSPLY SIRONA by 23.1% in the first quarter. MetLife Investment Management LLC now owns 59,453 shares of the medical instruments supplier’s stock valued at $2,926,000 after purchasing an additional 11,156 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in shares of DENTSPLY SIRONA by 6.6% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 29,250 shares of the medical instruments supplier’s stock valued at $1,440,000 after purchasing an additional 1,811 shares during the last quarter. Raymond James Trust N.A. raised its holdings in shares of DENTSPLY SIRONA by 61.7% in the first quarter. Raymond James Trust N.A. now owns 7,042 shares of the medical instruments supplier’s stock valued at $346,000 after purchasing an additional 2,687 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of DENTSPLY SIRONA by 6.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,833,372 shares of the medical instruments supplier’s stock valued at $90,243,000 after purchasing an additional 117,571 shares during the last quarter. Finally, Sei Investments Co. increased its holdings in DENTSPLY SIRONA by 18.9% during the first quarter. Sei Investments Co. now owns 468,759 shares of the medical instruments supplier’s stock worth $23,090,000 after buying an additional 74,629 shares during the last quarter. Institutional investors own 98.52% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on XRAY shares. William Blair raised shares of DENTSPLY SIRONA from an “underperform” rating to a “market perform” rating in a research report on Wednesday, January 11th. StockNews.com began coverage on DENTSPLY SIRONA in a research note on Wednesday, October 12th. They set a “hold” rating for the company. Morgan Stanley lowered their price objective on DENTSPLY SIRONA from $42.00 to $39.00 and set an “overweight” rating for the company in a research note on Tuesday, November 15th. Robert W. Baird lowered their price objective on DENTSPLY SIRONA to $32.00 in a research note on Thursday, November 17th. Finally, Evercore ISI increased their target price on shares of DENTSPLY SIRONA to $34.00 in a research report on Thursday, November 17th. Seven research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $40.70.

DENTSPLY SIRONA Trading Up 1.0 %

NASDAQ XRAY opened at $36.97 on Friday. The firm has a market capitalization of $7.95 billion, a P/E ratio of 13.69, a PEG ratio of 4.97 and a beta of 0.87. The business has a fifty day simple moving average of $32.15 and a 200 day simple moving average of $32.42. DENTSPLY SIRONA Inc. has a 12 month low of $26.48 and a 12 month high of $58.70. The company has a current ratio of 1.50, a quick ratio of 1.04 and a debt-to-equity ratio of 0.48.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last released its quarterly earnings results on Monday, November 14th. The medical instruments supplier reported $0.41 EPS for the quarter, missing analysts’ consensus estimates of $0.59 by ($0.18). DENTSPLY SIRONA had a negative net margin of 20.81% and a positive return on equity of 9.63%. The company had revenue of $947.00 million during the quarter, compared to analysts’ expectations of $1.01 billion. During the same period in the previous year, the company posted $0.68 earnings per share. The company’s quarterly revenue was down 8.9% compared to the same quarter last year. On average, analysts predict that DENTSPLY SIRONA Inc. will post 1.96 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 13th. Stockholders of record on Friday, December 30th were given a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 1.35%. The ex-dividend date of this dividend was Thursday, December 29th.

DENTSPLY SIRONA Profile

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

See Also

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.